Calamos Wealth Management LLC lessened its position in shares of UnitedHealth Group (NYSE:UNH) by 1.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 51,251 shares of the healthcare conglomerate’s stock after selling 668 shares during the period. UnitedHealth Group makes up 1.5% of Calamos Wealth Management LLC’s portfolio, making the stock its 13th biggest position. Calamos Wealth Management LLC’s holdings in UnitedHealth Group were worth $11,299,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of the business. Kingfisher Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $200,000. Mackenzie Financial Corp boosted its position in shares of UnitedHealth Group by 640.7% in the fourth quarter. Mackenzie Financial Corp now owns 53,088 shares of the healthcare conglomerate’s stock worth $11,704,000 after buying an additional 45,921 shares during the period. Buckingham Asset Management LLC boosted its position in shares of UnitedHealth Group by 3.3% in the fourth quarter. Buckingham Asset Management LLC now owns 10,963 shares of the healthcare conglomerate’s stock worth $2,417,000 after buying an additional 354 shares during the period. Commerce Bank boosted its position in shares of UnitedHealth Group by 1.1% in the fourth quarter. Commerce Bank now owns 170,465 shares of the healthcare conglomerate’s stock worth $37,581,000 after buying an additional 1,890 shares during the period. Finally, Hudson Bay Capital Management LP boosted its position in shares of UnitedHealth Group by 152.3% in the fourth quarter. Hudson Bay Capital Management LP now owns 126,161 shares of the healthcare conglomerate’s stock worth $27,813,000 after buying an additional 76,161 shares during the period. 86.80% of the stock is owned by hedge funds and other institutional investors.
Shares of NYSE UNH opened at $224.24 on Friday. UnitedHealth Group has a 52-week low of $164.67 and a 52-week high of $250.79. The company has a market cap of $219,456.27, a price-to-earnings ratio of 22.27, a PEG ratio of 1.32 and a beta of 0.77. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th were paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.34%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s payout ratio is currently 29.79%.
A number of brokerages recently commented on UNH. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $240.00 price target for the company in a report on Tuesday, April 3rd. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a report on Friday, March 9th. Cantor Fitzgerald reissued a “buy” rating and issued a $280.00 price target on shares of UnitedHealth Group in a report on Thursday, March 8th. Barclays began coverage on UnitedHealth Group in a report on Thursday, March 8th. They issued an “overweight” rating and a $265.00 price target for the company. Finally, Argus increased their price target on UnitedHealth Group to $270.00 and gave the company a “buy” rating in a report on Thursday, January 18th. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $244.06.
In other news, Director William C. Ballard, Jr. sold 10,000 shares of the stock in a transaction that occurred on Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total transaction of $2,463,800.00. Following the sale, the director now directly owns 76,637 shares in the company, valued at approximately $18,881,824.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kenneth Irwin Shine sold 198 shares of the stock in a transaction that occurred on Friday, January 19th. The stock was sold at an average price of $242.55, for a total value of $48,024.90. Following the sale, the director now owns 1,790,567 shares in the company, valued at $434,302,025.85. The disclosure for this sale can be found here. Insiders have sold 77,015 shares of company stock worth $17,879,199 in the last 90 days. 0.89% of the stock is currently owned by insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.